7.58
price up icon10.50%   0.72
after-market アフターアワーズ: 7.60 0.02 +0.26%
loading
前日終値:
$6.86
開ける:
$6.89
24時間の取引高:
219.59K
Relative Volume:
1.36
時価総額:
$162.03M
収益:
$66.59M
当期純損益:
$-104.93M
株価収益率:
-1.5313
EPS:
-4.95
ネットキャッシュフロー:
$-96.48M
1週間 パフォーマンス:
+6.46%
1か月 パフォーマンス:
+15.55%
6か月 パフォーマンス:
+1.07%
1年 パフォーマンス:
-39.89%
1日の値動き範囲:
Value
$6.6001
$7.63
1週間の範囲:
Value
$6.45
$7.73
52週間の値動き範囲:
Value
$4.09
$13.43

Enanta Pharmaceuticals Inc Stock (ENTA) Company Profile

Name
名前
Enanta Pharmaceuticals Inc
Name
セクター
Healthcare (1161)
Name
電話
617 607 0800
Name
住所
4 KINGSBURY AVENUE, WATERTOWN, MA
Name
職員
131
Name
Twitter
@EnantaPharma
Name
次回の収益日
2025-02-10
Name
最新のSEC提出書
Name
ENTA's Discussions on Twitter

ENTA を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
ENTA
Enanta Pharmaceuticals Inc
7.58 146.64M 66.59M -104.93M -96.48M -4.95
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
395.92 99.42B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
561.55 58.99B 14.21B 4.46B 3.56B 39.68
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
432.52 56.35B 2.46B -319.09M -52.09M -2.47
Biotechnology icon
ARGX
Argen X Se Adr
646.60 39.02B 3.06B 1.28B -614.78M 21.30
Biotechnology icon
ONC
Beone Medicines Ltd Adr
307.51 34.25B 3.81B -644.79M -669.77M -6.24

Enanta Pharmaceuticals Inc Stock (ENTA) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-07-28 再開されました H.C. Wainwright Buy
2023-08-09 ダウングレード JP Morgan Neutral → Underweight
2023-08-08 ダウングレード Jefferies Buy → Hold
2022-12-09 開始されました H.C. Wainwright Buy
2022-07-06 アップグレード Evercore ISI In-line → Outperform
2022-06-01 アップグレード Evercore ISI Underperform → In-line
2021-10-07 開始されました Jefferies Buy
2021-09-09 開始されました SVB Leerink Mkt Perform
2021-01-29 アップグレード JP Morgan Underweight → Neutral
2020-11-24 開始されました Evercore ISI Underperform
2020-08-28 再開されました ROTH Capital Buy
2020-08-26 開始されました Piper Sandler Overweight
2020-07-27 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2020-03-17 アップグレード Robert W. Baird Neutral → Outperform
2019-11-22 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2019-09-26 ダウングレード JP Morgan Neutral → Underweight
2019-05-24 開始されました Wolfe Research Outperform
2019-04-23 アップグレード Berenberg Hold → Buy
2018-12-13 開始されました Berenberg Hold
2018-06-06 開始されました ROTH Capital Buy
2018-02-08 ダウングレード JP Morgan Overweight → Neutral
2018-01-02 ダウングレード RBC Capital Mkts Outperform → Sector Perform
2017-11-21 繰り返されました RBC Capital Mkts Outperform
2017-09-15 開始されました RBC Capital Mkts Outperform
2017-07-11 アップグレード JMP Securities Mkt Perform → Mkt Outperform
2016-04-28 ダウングレード JMP Securities Mkt Outperform → Mkt Perform
2016-02-09 繰り返されました Barclays Underweight
2015-10-23 ダウングレード Barclays Equal Weight → Underweight
2015-10-23 アップグレード JMP Securities Mkt Perform → Mkt Outperform
すべてを表示

Enanta Pharmaceuticals Inc (ENTA) 最新ニュース

pulisher
Aug 13, 2025

Visualizing Enanta Pharmaceuticals Inc. stock with heatmapsJuly 2025 Opening Moves & Fast Moving Trade Plans - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Does Enanta Pharmaceuticals Inc. qualify in momentum factor screeningTrade Volume Report & Weekly Market Pulse Updates - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

What MACD and RSI say about Enanta Pharmaceuticals Inc.Gold Moves & Fast Entry Momentum Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Will Enanta Pharmaceuticals Inc. continue its uptrendMarket Activity Report & Weekly Chart Analysis and Guides - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

Has Enanta Pharmaceuticals Inc. Stock Ever Crashed Historical Volatility Review2025 Fundamental Recap & Daily Volume Surge Trade Alerts - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

How high can Enanta Pharmaceuticals Inc. stock go2025 Price Action Summary & High Conviction Investment Ideas - Newser

Aug 13, 2025
pulisher
Aug 13, 2025

JMP Securities Issues Positive Forecast for Enanta Pharmaceuticals (NASDAQ:ENTA) Stock Price - Defense World

Aug 13, 2025
pulisher
Aug 12, 2025

Citizens JMP raises Enanta Pharmaceuticals stock price target to $25 from $24 - Investing.com Canada

Aug 12, 2025
pulisher
Aug 12, 2025

Enanta Pharmaceuticals Sees Narrower Losses And Brighter Analyst Views - Finimize

Aug 12, 2025
pulisher
Aug 12, 2025

Order flow analysis tools used on Enanta Pharmaceuticals Inc.Daily Profit Watch With Forecast Confidence - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Top chart patterns to watch in Enanta Pharmaceuticals Inc.Free Capital Growth With Controlled Risk Picks - Newser

Aug 12, 2025
pulisher
Aug 12, 2025

Enanta Pharmaceuticals Reports Financial Results for its Fiscal Third Quarter Ended June 30, 2025 - BioSpace

Aug 12, 2025
pulisher
Aug 12, 2025

Enanta Pharmaceuticals Reports Steady Progress in Q3 2025 - TipRanks

Aug 12, 2025
pulisher
Aug 11, 2025

What makes Enanta Pharmaceuticals Inc. stock price move sharplyFree Entry Plan for Oversold Reversal Stocks - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Pharmaceuticals (ENTA) Reports Q3 Loss, Tops Revenue Estimates - sharewise.com

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Pharmaceuticals: Fiscal Q3 Earnings Snapshot - San Francisco Chronicle

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Pharmaceuticals shares rise 1.85% after-hours following positive RSVHR trial progress and FDA label expansion approval. - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Pharmaceuticals Inc reports results for the quarter ended June 30Earnings Summary - TradingView

Aug 11, 2025
pulisher
Aug 11, 2025

Enanta Q3 FY22 Revenue Down 17% YoY, Operations Supported by $204.1mln. - AInvest

Aug 11, 2025
pulisher
Aug 11, 2025

Detecting price anomalies in Enanta Pharmaceuticals Inc. with AIEquity Portfolio Outlook and Performance Summary - Newser

Aug 11, 2025
pulisher
Aug 11, 2025

Leading vs lagging indicators on Enanta Pharmaceuticals Inc. performanceFree Daily Profit Focused Stock Screener - Newser

Aug 11, 2025
pulisher
Aug 10, 2025

Will Enanta Pharmaceuticals Inc. price bounce be sustainableRisk-Managed Swing Setup and Signal Analysis - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

What technical models suggest about Enanta Pharmaceuticals Inc.’s comebackProfitable Trading Blueprint with Entry Zones - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

Is it too late to sell Enanta Pharmaceuticals Inc.Weekly Trend Watch with Market Signals - Newser

Aug 10, 2025
pulisher
Aug 10, 2025

How Interest Rate Changes Impact Enanta Pharmaceuticals Inc. Stock PerformanceSummary of Reliable Long-Term Trade Models - Newser

Aug 10, 2025
pulisher
Aug 09, 2025

Enanta Pharmaceuticals Inc. recovery potential after sell offSafe Entry Screening with Data Backed Analysis - Newser

Aug 09, 2025
pulisher
Aug 08, 2025

Enanta ENTA 2025Q3 Earnings Preview Downside Ahead on Weak Revenue Projections - AInvest

Aug 08, 2025
pulisher
Aug 06, 2025

XtalPi and DoveTree Announce Landmark $6 Billion AI Drug Discovery Collaboration - Seeking Alpha

Aug 06, 2025
pulisher
Aug 06, 2025

Enanta Pharmaceuticals Inc. Company Revenue and Profit Trends: A Deep DiveFree Trade Setups With Clear Risk Limits - Newser

Aug 06, 2025
pulisher
Aug 06, 2025

Enanta Pharmaceuticals to Participate in the H.C. Wainwright & Co. “HCW@Home” Series - BioSpace

Aug 06, 2025
pulisher
Aug 05, 2025

Enanta Pharmaceuticals to Participate in H.C. Wainwright & Co.'s Virtual Fireside Chat - AInvest

Aug 05, 2025
pulisher
Aug 04, 2025

Can volume confirm reversal in Enanta Pharmaceuticals Inc.Free Consistent Profit Pattern Recognition Tools - Newser

Aug 04, 2025

Enanta Pharmaceuticals Inc (ENTA) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$36.46
price up icon 1.67%
$85.85
price up icon 5.20%
$26.87
price up icon 4.61%
$122.87
price up icon 0.71%
$112.78
price up icon 1.60%
biotechnology ONC
$307.51
price up icon 6.74%
大文字化:     |  ボリューム (24 時間):